Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wuxi AppTec Co's Other Stockholders Equity for the quarter that ended in Jun. 2026 was ¥4,252 Mil.
Wuxi AppTec Co's quarterly Other Stockholders Equity
increased
from Dec. 2025 (¥3,936 Mil) to Mar. 2026 (¥34,277 Mil) but then
declined
from Mar. 2026 (¥34,277 Mil) to Jun. 2026 (¥4,252 Mil).
Wuxi AppTec Co's annual Other Stockholders Equity
increased
from Dec. 2023 (¥3,693 Mil) to Dec. 2024 (¥4,251 Mil) but then
declined
from Dec. 2024 (¥4,251 Mil) to Dec. 2025 (¥3,936 Mil).
Wuxi AppTec Co Other Stockholders Equity Related Terms
Wuxi AppTec Co Other Stockholders Equity Historical Data
* Premium members only.
The historical data trend for Wuxi AppTec Co's Other Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Stockholders Equity of ¥4,252 Mil mean?
Wuxi AppTec Co (SHSE:603259) has a Other Stockholders Equity of ¥4,252 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Wuxi AppTec Co and its competitors.
Is Wuxi AppTec Co's Other Stockholders Equity too high?
Wuxi AppTec Co's current Other Stockholders Equity is ¥4,252 Mil. Overall, Wuxi AppTec Co has a GF Score™ of 92/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Other Stockholders Equity compare to TMO and DHR?
Wuxi AppTec Co's Other Stockholders Equity of ¥4,252 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Wuxi AppTec Co and its competitors. Wuxi AppTec Co's current Other Stockholders Equity is ¥4,252 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (SHSE:603259) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥86.41, compared to a current price of ¥147.50 — trading 70.7% above its estimated fair value. The current Other Stockholders Equity is ¥4,252 Mil. Wuxi AppTec Co's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Wuxi AppTec Co (SHSE:603259), the current Other Stockholders Equity is ¥4,252 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wuxi AppTec Co (SHSE:603259) Overvalued in 2026?
Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued.
The current stock price of ¥147.50 is trading 70.7% above its estimated GF Value™ of ¥86.41.
GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.
Key valuation signals for SHSE:603259:
Other Stockholders Equity: ¥4,252 Mil
GF Value™: ¥86.41 vs. price of ¥147.50 (70.7% above fair value)
No single metric tells the full story. See the SHSE:603259 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
92GF Score
Get the complete analysis for SHSE:603259
Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603259 has been successfully added to your 
